Valuation: Cegedim

Market Cap 144M 164M 132M 122M 232M 15.66B 236M 1.58B 622M 7.71B 617M 603M 26.52B P/E 2026 *
7.12x
P/E 2027 * 4.74x
Enterprise Value 322M 368M 297M 274M 520M 35.09B 529M 3.55B 1.39B 17.28B 1.38B 1.35B 59.42B EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.43x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 week-0.76%
Current month-2.24%
1 month-7.10%
3 months-20.15%
6 months-23.09%
Current year-22.80%
1 week 10.34
Extreme 10.34
10.6
1 month 10.24
Extreme 10.24
11.6
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
22.6
5 years 8.5
Extreme 8.5
29.8
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Date Insider Type Main position Quantity % Market Cap.
Apr. 27Buy 74,537 0.5287%
Apr. 15Buy 500 0.0035%
Mar. 31Buy 1,239 0.0088%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.76%-3.15%-53.30% 164M
-2.14%+0.26%-40.15%+22.96% 405B
-0.12%-1.48%-47.71%+12.48% 184B
-1.04%+1.31%-44.37%-4.78% 111B
+2.44%-0.14%-43.45%+7.15% 42B
+0.80%-6.08%-77.56%+132.13% 33.28B
-2.23%-1.57%-21.05%+55.90% 29.01B
+1.63%+1.73%-33.76%+28.48% 17B
+0.21%-0.41%-34.65%+0.02% 12.31B
+0.80%+1.23%-39.53%+78.32% 11.33B
Average +0.34%-0.69%-38.54%+27.93% 84.49B
Weighted average by Cap. +0.06%-0.31%-43.11%+22.18%

Financials

2026 *2027 *
Net sales 660M 755M 609M 563M 1.07B 72.01B 1.09B 7.28B 2.86B 35.47B 2.83B 2.77B 122B 681M 779M 628M 580M 1.1B 74.27B 1.12B 7.51B 2.95B 36.59B 2.92B 2.86B 126B
Net income 21.25M 24.29M 19.6M 18.1M 34.35M 2.32B 34.93M 234M 91.97M 1.14B 91.22M 89.23M 3.92B 30.58M 34.96M 28.21M 26.05M 49.44M 3.33B 50.27M 337M 132M 1.64B 131M 128M 5.65B
Net Debt 178M 204M 164M 152M 288M 19.42B 293M 1.96B 771M 9.57B 765M 748M 32.9B 150M 171M 138M 128M 242M 16.33B 246M 1.65B 648M 8.04B 643M 629M 27.65B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
26-07-10 €10.46 0.00% 1,639
26-07-09 €10.46 -0.38% 105
26-07-08 €10.50 +0.19% 280
26-07-07 €10.48 +0.77% 2,139
26-07-06 €10.40 -1.33% 7,230
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
10.46EUR
Average target price
15.00EUR
Spread / Average Target
+43.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock